Literature DB >> 17241687

Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.

Luca Morandi1, Sofia Asioli, Alberto Cavazza, Annalisa Pession, Stefania Damiani.   

Abstract

Atypical adenomatous hyperplasia (AAH) has been recently defined by WHO as a small lesion, not exceeding 5mm in major axis, composed of slightly enlarged alveolar septa lined by pneumocytes with plump, atypical nuclei. AAH is frequently found in tissue surrounding lung adenocarcinoma and is considered a precursor of this subtype of lung cancer by many Authors. However, the genetic relationship between adenocarcinoma and the associated foci of AAH is not well defined. In particular, it is not clear whether multiple foci of AAH and of adenocarcinoma in the same patients are clonally related to each other or represent independent neoplastic foci. To clarify if AAH and the associated cancer are clonally related, we evaluated the genetic distance between these two lesions in 16 patients, using direct sequencing of mitochondrial DNA (D-loop region). Furthermore, LOH analysis for 7 microsatellites (D3S1478 at 3p21, D3S1300 at 3p14.2, D9S942 at 9p21, D5S346 at 5q21, D17S261 at 17p13.1, D18S46 at 18q21, D19S246 at 19q13.2) was also performed. Our results indicate that, in at least 9 out of 13 informative cases (69.2%), AAH and the associated cancer were not clonally related as they showed a different mutation pattern in the mitochondrial D-loop region. These findings were also in agreement with the LOH data which showed losses in different loci in at least three cases. On the contrary an identical LOH pattern between BAC and AAH was found in one case. Similar but not identical LOH pattern between AAH and related tumors was found in other three cases. Therefore, our results suggest that AAH and the associated cancer are genetically independent in agreement with the concept of cancerization field. Less frequently AAH foci could represent an early spread of cells from the main tumor, rather than a precursor lesion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17241687     DOI: 10.1016/j.lungcan.2006.11.022

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  12 in total

1.  Nasal seromucinous hamartoma (microglandular adenosis of the nose): a morphological and molecular study of five cases.

Authors:  Andrea Ambrosini-Spaltro; Luca Morandi; Dominic V Spagnolo; Alberto Cavazza; Massimo Brisigotti; Stefania Damiani; Sanjiv Jain; Vincenzo Eusebi
Journal:  Virchows Arch       Date:  2010-10-05       Impact factor: 4.064

2.  Ground-glass opacities showing an adenoma-to-carcinoma sequence in the lung.

Authors:  Haruhiko Nakamura; Takeshi Hirata; Masahiko Taguchi; Hajime Kitamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-08-13

3.  Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.

Authors:  Ye-Young Rhee; Tae-Hun Lee; Young Seok Song; Xianyu Wen; Hyojin Kim; Sanghoon Jheon; Choon-Taek Lee; Jei Kim; Nam-Yun Cho; Jin Haeng Chung; Gyeong Hoon Kang
Journal:  Virchows Arch       Date:  2015-03-13       Impact factor: 4.064

4.  Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung.

Authors:  Julien D F Licchesi; William H Westra; Craig M Hooker; Emi O Machida; Stephen B Baylin; James G Herman
Journal:  Carcinogenesis       Date:  2008-02-28       Impact factor: 4.944

Review 5.  Lung cancer screening with CT.

Authors:  Denise R Aberle; Kathleen Brown
Journal:  Clin Chest Med       Date:  2008-03       Impact factor: 2.878

6.  DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.

Authors:  Suhaida A Selamat; Janice S Galler; Amit D Joshi; M Nicky Fyfe; Mihaela Campan; Kimberly D Siegmund; Keith M Kerr; Ite A Laird-Offringa
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

7.  Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA.

Authors:  Evgeny Izumchenko; Xiaofei Chang; Mariana Brait; Elana Fertig; Luciane T Kagohara; Atul Bedi; Luigi Marchionni; Nishant Agrawal; Rajani Ravi; Sian Jones; Mohammad O Hoque; William H Westra; David Sidransky
Journal:  Nat Commun       Date:  2015-09-16       Impact factor: 14.919

8.  DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancers.

Authors:  Gerwin Heller; Corinna Altenberger; Bianca Schmid; Maximilian Marhold; Erwin Tomasich; Barbara Ziegler; Leonhard Müllauer; Christoph Minichsdorfer; György Lang; Adelheid End-Pfützenreuter; Balazs Döme; Britt-Madeleine Arns; Kwun M Fong; Casey M Wright; Ian A Yang; Walter Klepetko; Christoph C Zielinski; Sabine Zöchbauer-Müller
Journal:  Oncotarget       Date:  2015-01-01

9.  Cytogenetic findings in lung cancer that illuminate its biological history from adenomatous hyperplasia to bronchioalveolar carcinoma to adenocarcinoma: A case report.

Authors:  Daniela Bettio; Umberto Cariboni; Anna Venci; Marialuisa Valente; Paola Spaggiari; Marco Alloisio
Journal:  Exp Ther Med       Date:  2012-09-27       Impact factor: 2.447

10.  Solitary Atypical Adenomatous Hyperplasia in a 12-Year-Old Girl.

Authors:  Moran Jin; Yang-Haeng Lee; Bomi Kim; Young Chul Yoon; Jin Hong Wi
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.